explore -WSS

explore

author：leisure time 2025-09-30 18:00:39 - browse：17213

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： The debate over Covid

WSS

The EU Joint Clinical Assessment needs to live up to its promise

A Greenpeace activist is fined for crash

Vermont grapples with historic flooding as more rainstorms head for Northeast

Women's World Cup brings attention to abuse in soccer

Will Ozempic

Lawmakers consider Medicare pay reforms for doctors

focus

explore

hotspot

Guidelines to prevent youth baseball injuries need more muscle

How are insurers handling Leqembi and related scans?

Trump demands the U.S. pay no more for drugs than other countries … again

How climate

Cancer drug shortages should be causing more outrage

Women's World Cup brings attention to abuse in soccer

How one medical school became remarkably diverse

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Grail's uphill battle for Medicare to cover its cancer screening test

focus

FDA warns J&J's Abiomed: We will regulate your software

STAT Summit: How a Chicago ER doctor tackles gun violence

Senate committee scrutinizes Medicare Advantage brokers

STAT Readout Newsletter: Today's biggest biotech updates

UnitedHealth’s board chair also owns a personal investment firm

NIH confirmation hearing shows politicization of research

focus

Wikipedia

focus

Wikipedia